Therefore, EFE or pseudo-Kampo medicines containing EFE instead of Ephedra herb could be utilized as treatments for c-Met-expressing cancer patients, because ephedrine alkaloid-induced side effects should not limit their use. This evidence concerns the gene MET and cancer.